Global Hemophilia B Market 2015 - 2019

Hexa Reports

Market Research Reports and Insightful Company Profiles

Global Hemophilia B Market Size and Share, Growth,

Market Price, Analysis, Forecast and Overview 2015 2019

Hemophilia B, also called the Christmas disease, is a blood coagulation disorder due to the deficiency or

improper function of factor IX. It is inherited in an X-linked recessive pattern. This disorder is more

prevalent in males than in females. Factor replacement therapies, mainly recombinant, are used in the

treatment.

Browse Detail Report With TOC @ http://www.hexareports.com/report/global-hemophilia-bmarket/details

Covered in this report

The report includes the present scenario and the growth prospects of the global hemophilia B market

for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of

various drugs used in the treatment of hemophilia B.

Table Of Content

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

Hexa Reports

Market Research Reports and Insightful Company Profiles

Request A Sample copy of This Report @ http://www.hexareports.com/sample/50090

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Disease overview

Understanding the disease

Epidemiology

PART 07: Pipeline portfolio

Key information of few pipeline candidates

PART 08: Market segmentation by disease severity

Mild hemophilia B

Moderate hemophilia B

Severe hemophilia B

PART 09: Market segmentation by disease management

On-demand therapy

Prophylactic therapy

Inhibitor therapy

PART 10: Geographical segmentation

PART 11: Market drivers

Focus on prophylactic treatment

Drugs with prolonged action

Patient assistance programs

PART 12: Impact of drivers

PART 13: Market challenges

High cost of therapy

Low...